title: Differential regulation of parvalbumin and calretinin interneurons in the prefrontal cortex during adolescence.
abstract: Determining the normal developmental trajectory of individual GABAergic components in the prefrontal cortex (PFC) during the adolescent transition period is critical because local GABAergic interneurons are thought to play an important role in the functional maturation of cognitive control that occurs in this developmental window. Based on the expression of calcium-binding proteins, three distinctive subtypes of interneurons have been identified in the PFC: parvalbumin (PV)-, calretinin (CR)-, and calbindin (CB)-positive cells. Using biochemical and histochemical measures, we found that the protein level of PV is lowest in juveniles [postnatal days (PD) 25-35] and increases during adolescence (PD 45-55) to levels similar to those observed in adulthood (PD 65-75). In contrast, the protein expression of CR is reduced in adults compared to juvenile and adolescent animals, whereas CB levels remain mostly unchanged across the developmental window studied here. Semi-quantitative immunostaining analyses revealed that the periadolescent upregulation of PV and the loss of the CR signal appear to be attributable to changes in PV- and CR-positive innervation, which are dissociable from the trajectory of PV- and CR-positive cell number. At the synaptic level, our electrophysiological data revealed that a developmental facilitation of spontaneous glutamatergic synaptic inputs onto PV-positive/fast-spiking interneurons parallels the increase in prefrontal PV signal during the periadolescent transition. In contrast, no age-dependent changes in glutamatergic transmission were observed in PV-negative/non fast-spiking interneurons. Together, these findings emphasize that GABAergic inhibitory interneurons in the PFC undergo a dynamic, cell type-specific remodeling during adolescence and provide a developmental framework for understanding alterations in GABAergic circuits that occur in psychiatric disorders.
authors: Department of Cellular and Molecular Pharmacology, The Chicago Medical School at Rosalind Franklin University of Medicine and Science, 3333 Green Bay Rd, North Chicago, IL, 60064, USA.
authors: Adriana
authors: A
authors: Caballero
authors: Eden
authors: E
authors: Flores-Barrera
authors: Daryn K
authors: DK
authors: Cass
authors: Kuei Y
authors: KY
authors: Tseng
mesh_terms: D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn; D001710:Biotin / Q000031:analogs & derivatives / Q000378:metabolism; D064032:Calbindin 2 / Q000378:metabolism*; D064026:Calbindins / Q000378:metabolism; D002452:Cell Count; D018507:Gene Expression Regulation, Developmental / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D007395:Interneurons / Q000502:physiology*; D008297:Male; D010320:Parvalbumins / Q000378:metabolism*; D018408:Patch-Clamp Techniques; D017397:Prefrontal Cortex / Q000166:cytology* / Q000254:growth & development; D051381:Rats; D017207:Rats, Sprague-Dawley; D018709:Statistics, Nonparametric
chemical_list: D064032:Calbindin 2; D064026:Calbindins; D010320:Parvalbumins; C070614:neurobiotin; D001710:Biotin
references: Anat Embryol (Berl). 1991;184(2):103-24
references: 1952098
references: Schizophr Res. 2002 Sep 1;57(1):27-34
references: 12165373
references: Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5341-6
references: 9560277
references: Cell Tissue Res. 1993 Feb;271(2):181-208
references: 8453652
references: Arch Gen Psychiatry. 2000 Mar;57(3):237-45
references: 10711910
references: J Neurosci. 2006 Feb 1;26(5):1604-15
references: 16452684
references: BMC Med Genomics. 2009 May 20;2:28
references: 19457239
references: Schizophr Bull. 2011 May;37(3):493-503
references: 21505116
references: J Comp Neurol. 1991 Nov 22;313(4):574-86
references: 1783682
references: J Comp Neurol. 1996 Jan 22;364(4):567-608
references: 8821449
references: Child Dev. 2010 Nov-Dec;81(6):1641-60
references: 21077853
references: Child Dev. 2004 Sep-Oct;75(5):1357-72
references: 15369519
references: Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
references: 10817843
references: J Comp Neurol. 1995 Apr 24;355(1):81-92
references: 7636016
references: J Neurosci. 2003 Jul 16;23(15):6315-26
references: 12867516
references: Eur J Neurosci. 2006 May;23(10):2581-94
references: 16817861
references: J Comp Neurol. 1995 Feb 20;352(4):567-93
references: 7722001
references: Nat Rev Neurosci. 2010 Feb;11(2):100-13
references: 20087360
references: Schizophr Bull. 2011 May;37(3):514-23
references: 21505118
references: Cold Spring Harb Perspect Biol. 2010 Nov;2(11):a004051
references: 20943758
references: J Neurosci. 2008 Nov 26;28(48):12691-9
references: 19036962
references: Anat Embryol (Berl). 1993 Jul;188(1):63-73
references: 8214625
references: J Comp Neurol. 1988 Nov 8;277(2):195-213
references: 2466057
references: Neuropsychologia. 1990;28(6):517-27
references: 2203993
references: Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):3-18
references: 12732219
references: J Physiol. 2012 Feb 15;590(4):669-81
references: 22250212
references: Behav Brain Res. 2009 Dec 7;204(2):295-305
references: 19100784
references: Neuroscientist. 2012 Dec;18(6):613-30
references: 21952258
references: Brain Res Rev. 2007 Nov;56(1):1-26
references: 17559940
references: Neuropsychopharmacology. 2001 Jul;25(1):1-27
references: 11377916
references: Nat Rev Neurosci. 2008 Dec;9(12):947-57
references: 19002191
references: Am J Psychiatry. 2003 Jun;160(6):1041-52
references: 12777258
references: Cereb Cortex. 1997 Sep;7(6):476-86
references: 9276173
references: J Neurosci. 2003 Nov 5;23(31):9987-95
references: 14602812
references: J Comp Neurol. 1997 May 19;381(4):389-410
references: 9136798
references: J Comp Neurol. 2005 Sep 26;490(3):220-38
references: 16082676
references: Synapse. 1996 Aug;23(4):237-45
references: 8855508
references: Science. 2007 Dec 7;318(5856):1645-7
references: 18063801
references: J Comp Neurol. 1997 Oct 13;387(1):12-26
references: 9331168
references: Neuropharmacology. 2011 May;60(6):953-62
references: 21288471
references: Brain Res. 1981 Jul 27;217(1):150-4
references: 7260612
references: J Comp Neurol. 1997 Mar 3;379(1):113-32
references: 9057116
references: Cereb Cortex. 2005 Jan;15(1):49-57
references: 15217899
references: Schizophr Bull. 2011 May;37(3):484-92
references: 21505115
references: Proc Biol Sci. 2010 Apr 7;277(1684):1011-20
references: 19955152
references: Brain Struct Funct. 2007 Sep;212(2):149-79
references: 17717690
references: Biol Psychol. 2000 Oct;54(1-3):241-57
references: 11035225
references: J Comp Neurol. 1996 Feb 12;365(3):367-79
references: 8822176
references: J Comp Neurol. 1997 Jan 27;377(4):465-99
references: 9007187
references: J Comp Neurol. 1994 Mar 1;341(1):95-116
references: 8006226
references: Neuroscience. 1988 Feb;24(2):379-431
references: 2452377
references: Cereb Cortex. 2007 May;17(5):1235-40
references: 16818475
references: Pharmacol Biochem Behav. 2007 Feb;86(2):189-99
references: 17222895
references: Nat Rev Neurosci. 2008 Jul;9(7):557-68
references: 18568015
references: J Neurosci. 2000 Jan 1;20(1):485-94
references: 10627624
references: Nat Neurosci. 2011 Dec 04;15(1):20-2
references: 22138646
references: Cereb Cortex. 1996 Mar-Apr;6(2):271-87
references: 8670656
references: Jpn J Physiol. 1994;44 Suppl 2:S145-8
references: 7538606